Anupam Rasayan announced a ₹300 Crore acquisition of a 43.3-48.2% stake in Bliss GVS Pharma Limited. The deal integrates its specialty chemical capabilities with pharmaceutical formulations.
Kings Infra Ventures Ltd scheduled a board meeting for May 29, 2026. Directors will consider and approve audited standalone and consolidated financial results.
Prism Medico and Pharmacy scheduled a board meeting on May 28, 2026. Directors will consider audited standalone financial results for the quarter and year ended March 2026.
Independent Director Ratna Dharashree Vishwanathan completed her final tenure on May 23, 2026. The departure follows the statutory conclusion of her second term on the Board.
Sunshine Capital Ltd disclosed related party transactions involving loans given totaling ₹43.69 Crore. These transactions occurred during the fiscal period ended March 31, 2026.
Remsons Industries corrected a typographical error in its board meeting notice. The meeting will consider an interim dividend for financial year 2025-26 on May 27.
Savera Industries reported annual financial results for FY26 and recommended a final dividend of ₹3 per share. The 57th Annual General Meeting is scheduled for September 2026.
Rainbow Children’s Medicare Limited reported strong Q4 FY26 performance with 24% YoY revenue growth and 26% EBITDA growth. Strategy focuses on deepening the 'Hub and Spoke' model across major Indian cities.
Gloster Limited is merging two wholly-owned subsidiaries into itself to improve capital efficiency. The transaction involves no cash consideration and leaves the listed entity's shareholding unchanged.
Jainam Ferro Alloys appointed Mr. Ashish Krishnani as Internal Auditor and re-appointed Arindam & Associates as Cost Auditor. Both appointments carry 12-month terms.
India Pesticides re-appointed Seth & Associates and Honey Singh & Associates as internal and cost auditors. Both appointments are for 12-month terms effective May 2026.
Precision Wires India Limited recommended a final dividend of ₹0.55 per equity share. The board approval strengthens shareholder returns pending final general meeting confirmation.
Sarvottam Finvest submitted its Annual Secretarial Compliance Report for FY 2025-26. The auditor confirmed adherence to SEBI regulations and maintenance of the Structured Digital Database.
Rajputana Biodiesel approved its audited standalone and consolidated financial results for fiscal 2026. The board also re-appointed M/s. R. P. Khandelwal & Associates as internal auditors.
Sunshine Capital reported audited financial results for the year ended March 2026. The board also confirmed non-applicability of SEBI Regulation 32 regarding use of proceeds.
Reliance Infrastructure reported a total consolidated income of ₹20,862.03 Crore for FY2025-26. The board also appointed new statutory and secretarial auditors and approved a ₹3,000 Crore fundraise.
Swashthik Plascon reported FY26 standalone total revenue of ₹52.75 Crore. The board also appointed M/s. M.P. Singh and Co. as internal auditors for FY27.
Rainbow Children’s Medicare reported strong Q4 results with 24.3% revenue growth. The company completed its capacity expansion phase, shifting focus to execution and operational optimization.
Polyplex Corporation appointed Ranjit Singh as a Non-Executive Director following Sanjiv Chadha's resignation. These leadership changes ensure continuity in board oversight and corporate governance.
Bhudevi Infra Projects approved the re-appointment of M/s. Swati Doogar & Co. as internal auditor for FY 2026-27. The board meeting concluded successfully today.
Gabion Technologies India Limited approved audited FY26 results, reporting consolidated revenue of ₹115.20 Crore. The company also confirmed utilization of ₹28.09 Crore from IPO proceeds.